Serial Measurement of Serum Antimullerian Hormone in Women Undergoing Laparoscopic Cystectomy of Endometrioma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Mahidol University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Mahidol University
ClinicalTrials.gov Identifier:
NCT01065168
First received: February 6, 2010
Last updated: February 16, 2010
Last verified: January 2009
  Purpose

The purpose of this trial is to study ovarian reserve after laparoscopic endometrioma cystectomy by measuring antimullerian hormone. The measurements were measured before the surgery and one week and three months after the surgery.


Condition
Endometriosis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Serial Measurement of Serum Antimullerian Hormone in Women Undergoing Laparoscopic Cystectomy of Endometrioma

Resource links provided by NLM:


Further study details as provided by Mahidol University:

Primary Outcome Measures:
  • Ovarian reserve before and after ovarian endometrioma cystectomy. [ Time Frame: one week and three months ] [ Designated as safety issue: Yes ]

Enrollment: 43
Study Start Date: January 2009
Estimated Study Completion Date: March 2010
Estimated Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
endometrioma
ovarian endometrioma undergoing cystectomy

Detailed Description:

Antimullerian hormone will be obtained in patients with ovarian endometrioma before laparoscopic cystectomy is done. The measurements were compared with antimullerian hormone after one week and three months after the surgery. Forty three patients will be included in this study.

  Eligibility

Ages Eligible for Study:   20 Years to 40 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

ovarian endometrioma performed laparoscopic cystectomy

Criteria

Inclusion Criteria:

  • 20-40 years
  • ovarian endometrioma > or = 3 cms
  • laparoscopic cystectomy treatment

Exclusion Criteria:

  • previous ovarian surgery
  • other ovarian pathology
  • previous drugs or hormonal treatment for endometrioma
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01065168

Sponsors and Collaborators
Mahidol University
Investigators
Principal Investigator: Singpetch Suksompong, Doctor Mahidol University
  More Information

No publications provided

Responsible Party: Singpetch Suksompong, Mahidol University
ClinicalTrials.gov Identifier: NCT01065168     History of Changes
Other Study ID Numbers: si637/2008
Study First Received: February 6, 2010
Last Updated: February 16, 2010
Health Authority: Thailand: Ethical Committee

Keywords provided by Mahidol University:
endometriosis
endometrioma
antimullerian hormone
cystectomy

Additional relevant MeSH terms:
Endometriosis
Genital Diseases, Female
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on September 16, 2014